Moderate and severe plaque psoriasis: cost-of-illness study in Italy.

Therapeutics and Clinical Risk Management
Gl ColomboS Chimenti

Abstract

Psoriasis is a chronic inflammatory, immune-mediated skin disorder that affects 1.5-1.8 million people in Italy. The most common form of the disease is chronic plaque psoriasis, affecting about 90% of psoriasis patients, with about 20%-30% of them suffering from a moderate or severe condition. Little information is available about the economic impact of psoriasis in European countries. The primary objective of this study was to perform a cost-of-illness analysis of patients with moderate and severe plaque psoriasis in Italy. Therefore, direct, indirect costs, and intangible costs (quality of life - QoL) were assessed. In this national, multicenter, prospective, 3-month cost-of-illness study of moderate and severe plaque psoriasis, direct and indirect costs were assessed from the patient, third-party payer (National Health Service, NHS), and societal perspectives. From November 2003 to October 2004 consecutive patients were enrolled over a 1-year period, in order to minimize seasonal fluctuations in disease severity. 150 patients enrolled in 6 investigational sites in Italy, completed the study, and were eligible to be analyzed according to the study protocol. Intangible costs (QoL) were measured using SF36 and DLQI questionnair...Continue Reading

Citations

Dec 20, 2019·International Journal of Psychiatry in Clinical Practice·Maria LucaGiuseppe Micali
Jul 27, 2012·BMC Dermatology·Georgia AvgerinouLoukas Xaplanteris
Aug 17, 2014·BMC Health Services Research·Anssi MustonenRisto Tuominen
Jul 24, 2014·Expert Review of Pharmacoeconomics & Outcomes Research·Steven R FeldmanUsha G Mallya
Apr 19, 2015·BMC Health Services Research·Anssi MustonenRisto Tuominen
Aug 12, 2009·Current Medical Research and Opinion·Andrew P YuParvez M Mulani
Dec 15, 2010·Current Medical Research and Opinion·Keith FreemanJacob Ryttov
Sep 22, 2012·PharmacoEconomics·Giovanna RahoLuigi Naldi
Jul 30, 2014·International Journal of Dermatology·Dóris B MenegonTania Cestari
Feb 26, 2014·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Federico SpandonaroPiergiacomo Calzavara Pinton
Dec 2, 2017·Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia·Maria LucaGiuseppe Micali
Oct 22, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Nicole C RouseSteven R Feldman
Feb 5, 2016·Experimental Dermatology·Britta C MartelLars K Poulsen
May 28, 2016·Journal of Managed Care & Specialty Pharmacy·Alain TaiebEvelina Bertranou
Dec 18, 2013·Dermatology and Therapy·Anssi MustonenRisto Tuominen
Feb 19, 2010·The British Journal of Dermatology·R J B DriessenE M G J De Jong
Sep 30, 2010·The British Journal of Dermatology·A D Burden
Aug 24, 2019·International Journal of Health Policy and Management·Nor Azmaniza AzizamNorazirah Md Nor
Jun 25, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·C E GriffithsJ A Leman
Oct 9, 2014·The British Journal of Dermatology·L-T KaoS-D Chung
Sep 16, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·B PolistenaF Ayala

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.